Abstract
The treatment of ventricular arrhythmias in patients with chronic ischemic cardiomyopathy has evolved over the decades from a primarily medical approach to one dominated by technology and invasive interventions. While the implantable cardioverter-defibrillator has offered extended life to many patients, recurrent ventricular arrhythmias are the cause of significant morbidity still. A complex, multi-modality approach by expert clinicians is necessary for successful management of these patients. Future technological advances will allow for the effective treatment of more patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
